Which nursing consideration(s) would be taken into account prior to the administration of cisplatin IV? (Select all that apply.)

Question

a. Review of laboratory data for presence of myelosuppression and hepatic and renal parameters
b. Administration of IV hydration as prescribed
c. Administration of epoetin alfa (Epogen)
d. Administration of prechemotherapy mesna (Mesnex)
e. Assessment for dermatologic conditions

Answer 1

ANS: A, B, D
Premedication nursing considerations regarding cisplatin, an alkylating agent, include checking laboratory reports for baseline data reflecting hepatic and renal function and baseline hematologic studies that reflect the degree of myelosuppression present before initiating chemotherapy, assessing patient hydration and the health care provider's orders for oral and IV hydration instructions before drug therapy, and administering prechemotherapy drugs including mesna, ondansetron, and antianxiety drugs. Epogen is given to treat anemia associated with chemotherapy; it is not given before administration of chemotherapy. Dermatologic assessment is not necessary before administering cisplatin.